Atea Pharmaceuticals Inc.

03/28/2022 | Press release | Distributed by Public on 03/29/2022 13:18

4793: Lack of Reproductive and Developmental Toxicity for AT-527 (Bemnifosbuvir), an Oral Purine Nucleotide Prodrug for COVID-19 Infection